Moderna (NasdaqGS:MRNA) plans to present Phase 1/2 data for its mRNA-4359 cancer antigen therapy combined with pembrolizumab ...

A recent clinical trial using an mRNA vaccine helped to greatly extend the lives of people with pancreatic cancer and a new ...

An mRNA vaccine for avian influenza, developed by pharma company Moderna, has begun Phase 3 human trials. Building on the ...

The treatment staved off cancer for seven of eight patients with a condition where the odds are rarely that good.

Indian American physician-scientist Dr. Vinod Balachandran says mRNA vaccines may reduce risk of disease coming back after ...

Add Yahoo as a preferred source to see more of our stories on Google. Health and Human Services Secretary Robert F. Kennedy Jr. canceled $500 million of funding for research on mRNA vaccine technology ...

The Department of Health and Human Services had canceled hundreds of millions of dollars in funding previously committed help ...

Add Yahoo as a preferred source to see more of our stories on Google. The United States is turning its back on what could be the greatest medical advance in a generation — vaccines made with messenger ...

Messenger RNA technology, better known as mRNA technology, made it possible to rapidly deploy a new vaccine during the COVID-19 pandemic — much earlier than would otherwise have been possible, saving ...

EDITOR’S NOTE: The views expressed in this commentary are solely those of the writer. CNN is showcasing the work of The Conversation, a collaboration between journalists and academics to provide news ...

One of the beneficial characteristics of the response to the COVID -19 pandemic were pledges from companies involved in developing vaccines (such as Moderna, Pfizer, BioNTech, and others) not to ...